Literature DB >> 17715829

Thailand diabetes registry project: type of diabetes, glycemic control and prevalence of microvascular complications in children and adolescents with diabetes.

Supawadee Likitmaskul1, Suttipong Wacharasindhu, Petch Rawdaree, Chardpraorn Ngarmukos, Chaicharn Deerochanawong, Sompongse Suwanwalaikorn, Thanya Chetthakul, Pongamorn Bunnag, Natapong Kosachunhanun, Nattachet Plengvidhaya, Rattana Leelawatana, Sirinate Krittiyawong, Yupin Benjasuratwong, Thongchai Pratipanawatr.   

Abstract

OBJECTIVE: To determine the etiology, glycemic control and prevalence of microvascular complications in Thai diabetic patients who were diagnosed at the age of less than 18 years and who attended diabetes clinics in university or tertiary care hospitals. MATERIAL AND
METHOD: A cross-sectional, multi-center, hospital-based diabetes registry was carried out from diabetes clinics of 11 tertiary centers. Demographic data including laboratory results and microvascular complications were recorded.
RESULTS: Two-hundred-and-fifty out of the 9419 (2.66%) diabetic patients were diagnosed before the age of 18 years, 78% had Type 1 diabetes (T1DM), 18.4% had Type2 diabetes (T2DM) and 3.6% had other types of diabetes. Mean +/- SD HbAlc of T1DM was 9.3 +/- 2.5, T2DM was 9.7 +/- 2.6 and other types of diabetes were 8.6 +/- 4%. The majority of patients had poor glycemic control according to ADA and WHO guidelines. The percentage of patients who had diabetes for more than 5 years but had not been screened for nephropathy and retinopathy were 57.7% and 16% in T1DM and were 46.4% and 14.2% in T2DM respectively. A significant correlation between microvacular complications (nephropathy and retinopathy) and duration of disease was found in T1DM (p < 0.001).
CONCLUSION: The majority of Thai children and adolescents with diabetes had TIDM and unsatisfactory glycemic control. Screening for microvascular complications was under international standard. The national strategic plan for management of this disease especially in this age group should be urgently implemented.

Entities:  

Mesh:

Year:  2006        PMID: 17715829

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  6 in total

Review 1.  Trends of increases in potential risk factors and prevalence rates of diabetes mellitus in Thailand.

Authors:  V Chavasit; W Kriengsinyos; J Photi; K Tontisirin
Journal:  Eur J Clin Nutr       Date:  2017-04-19       Impact factor: 4.016

Review 2.  Diabetes in Thailand: Status and Policy.

Authors:  Sirimon Reutrakul; Chaicharn Deerochanawong
Journal:  Curr Diab Rep       Date:  2016-03       Impact factor: 4.810

3.  Trends of childhood diabetes in Southern Thailand: 20-year experience in a tertiary medical center.

Authors:  Somchit Jaruratanasirikul; Sudarat Thammaratchuchai; Hutcha Sriplung
Journal:  World J Pediatr       Date:  2017-10-20       Impact factor: 2.764

Review 4.  Diabetes management in Thailand: a literature review of the burden, costs, and outcomes.

Authors:  Chaicharn Deerochanawong; Alessandra Ferrario
Journal:  Global Health       Date:  2013-03-14       Impact factor: 4.185

5.  Epidemiology and phenotypes of diabetes in children and adolescents in non-European-origin populations in or from Western Pacific region.

Authors:  Steven James; Jayanthi Maniam; Pik-To Cheung; Tatsuhiko Urakami; Julia von Oettingen; Supawadee Likitmaskul; Graham Ogle
Journal:  World J Clin Pediatr       Date:  2022-03-09

6.  Type 1 diabetes management and outcomes: A multicenter study in Thailand.

Authors:  Prapai Dejkhamron; Jeerunda Santiprabhob; Supawadee Likitmaskul; Chaicharn Deerochanawong; Petch Rawdaree; Thipaporn Tharavanij; Sirimon Reutrakul; Chawkaew Kongkanka; Chittiwat Suprasongsin; Nawaporn Numbenjapon; Taninee Sahakitrungruang; Raweewan Lertwattanarak; Pontipa Engkakul; Apiradee Sriwijitkamol; Manassawee Korwutthikulrangsri; Rattana Leelawattana; Mattabhorn Phimphilai; Somkiat Potisat; Panthep Khananuraksa; Cherdchai Nopmaneejumruslers; Wannee Nitiyanant
Journal:  J Diabetes Investig       Date:  2020-10-04       Impact factor: 4.232

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.